卡托普利与氯沙坦治疗充血性心力衰竭的临床研究被引量：4

Effect of losartan and captopril on congestive heart failure

在线阅读下载PDF

导出

摘要目的 :评价血管紧张素Ⅱ受体拮抗剂、血管紧张素转换酶抑制剂 (ACEI)及两者合用治疗充血性心力衰竭的临床效果。方法 :6 0例患者随机分为卡托普利组、氯沙坦组和联合用药组 ,于入院时行NYHA心功能分级 ,超声心动图测定左室射血分数 (LVEF)、左室收缩末容积 (LVESV)、左室舒张末容积 (LVEDV) ,治疗 1、3、6、12个月复查上述指标。结果 :卡托普利组与联合用药组治疗 1个月时心功能、LVESV、LVEDV、LVEF值均有显著改善 ,优于氯沙坦组 ,卡托普利组LVEF和LVESV有随着服药时间的延长进一步好转的趋势 ,联合用药组用药 3个月后各项指标处于稳定状态 ,氯沙坦组服药 3个月各项指标才开始发生变化 ,服药 3、6、12个月 3组间比较差异无统计学意义。结论 :血管紧张素Ⅱ受体拮抗剂与ACEI均可逆转左心室重塑和防治心力衰竭 ,在心力衰竭的长期治疗中可获得相同的益处 ,但心力衰竭急性期宜选用ACEI ,可尽快改善临床症状 ,联合应用两种药物并未显示出叠加的优势且增加了患者的经济负担。 Objective: To compare the effect of angiotensin Ⅱ antagonist (AngⅡA) losartan with angiotensin converting enzyme inhibitors (ACEI) captopril and the combination of the two agents on congestive heart failure. Methods: Sixty patients with ischemic cardiomyopathy or dilated cardiomyopathy are randomly divided into 3 groups: captopril group, losartan group, combination group. Clinical parameters, including heart function, assessed by NYHA, and LVEF, LVESV, LVEDV, measured by echocardiography, are recorded at the beginning and 1,3,6,12 months after therapy. Results: The parameters after treatment were respectively different from those before. Heart function, LVESV, LVEDV, LVEF of the captopril group or combination group have improved obviously after 1 month therapy compared with those of losartan group. LVEF and LVESV of captopril group show the trend of increase with prolongation of treatment. The parameters of combination group show the tendancy of stable after 3 months. The parameters of losartan group increased significantly in 3 months than before. The change of the three groups have no statistically significant in 3?6?12 month. Conclusion: Both angiotensin Ⅱ antagonist (AngⅡA) and angiotensin coverting enzyme inhibitors(ACEI) can reverse the myocardial remodeling, prevent the progress of heart failure and improve the heart function. They have equal effect on long term treatment of heart failure. But in acute period, ACEI is better than losartan because it can immediately improve the symptom. The combination of two agents hasn't shown the benefit and increase the financial burden of the patients.

作者汤宝鹏孙惠萍马依彤程祖亨杨毅宁张燕一再帕尔.肉孜阿吉黄焰阿迪拉.阿扎提

机构地区新疆医科大学第一附属医院心内科

出处《新疆医科大学学报》 CAS 2003年第5期421-424,共4页 Journal of Xinjiang Medical University

关键词卡托普利氯沙坦超声心动图充血性心力衰竭 captopril losartan echocardiography congestive heart failure

分类号 R972 [医药卫生—药品] R541.61 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献8

1The SOLVD investigutors. Effect of enalapril on survival in patients with reduced left ventricular ejection and congestive heart failure[J]. N Engl J Med, 1991,325 : 239-302.
2Messerli FH, Weber MA, Brunner HR. Angiotensin Ⅱ receptor inhibition: A new therapeutic [J]. Arch Intern Med,1996,156(17) : 1957-1965.
3Kang PM, Landau AJ, Eberhardt RT, et al. Angiotensin I receptor antagonists: a new approach to blockade of the reninangiotensin system[J]. Am Heart J, 1994, 127: 1388-1401.
4Cleland JG, Morgan K. Inhibition of the rein-angiotensinaldosterone system in heart failure: new insights from basic clinical research[J]. Curt Opin Cardiort, 1996, 11 : 252-262.
5Brunner HP, Rocca MD, Vaddadi G, et al. Recem insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-Ⅱ antagonoism [J]. J Am Coil Cardiol, 1999, 33(5): 1163-1173.
6Pfeifer. Effect of captorial on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarctions results of the survival and ventricular enlargement trial[J]. N Engl J Med,1992,327:656-669.
7Stmthers AD. Angiotensin Ⅱ receptor antagonists for heart failure[J]. Heart, 1998,80: 5-6.
8Pitt B, Pool-Wilson PA, Segal R, et al. Effect of losartan compared with catoppril on mortality in patients with symptomatic heart failure : randomized trial-the losartan heart failure survival study ELITE 11 [J]. Lancet, 2000, 355(9215) :1582-1587.